Cargando…
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022
Autores principales: | Adjei, Stacey, Hong, Kai, Molinari, Noelle-Angelique M., Bull-Otterson, Lara, Ajani, Umed A., Gundlapalli, Adi V., Harris, Aaron M., Hsu, Joy, Kadri, Sameer S., Starnes, Jon, Yeoman, Kristin, Boehmer, Tegan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484808/ https://www.ncbi.nlm.nih.gov/pubmed/36107788 http://dx.doi.org/10.15585/mmwr.mm7137a4 |
Ejemplares similares
-
Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022
por: Kompaniyets, Lyudmyla, et al.
Publicado: (2022) -
Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021
por: Bull-Otterson, Lara, et al.
Publicado: (2022) -
Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021
por: Yek, Christina, et al.
Publicado: (2022) -
Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020
por: Bull-Otterson, Lara, et al.
Publicado: (2020) -
April-June 2008
Publicado: (2008)